The Peptide Therapy Research Hub
Evidence-based guides written for patients, not practitioners.
Is BPC-157 Legal? The Complete Answer for 2026
The honest answer is more nuanced than most sites admit. Here is exactly where BPC-157 stands legally, what changed in 2023, and what the July 2026 FDA panel means for patients.
BPC-157: What It Is, What the Research Shows, and What It Does Not Show
BPC-157 has been called everything from a miracle peptide to a scam. The truth is in the research, and the research is more interesting than either claim.
Thymosin Alpha-1 and the Immune System: What Patients Need to Know
Thymosin Alpha-1 is one of the most studied peptides for immune function. Here is what the research shows, who uses it, and what to realistically expect.
Starting Peptide Therapy: A Realistic Guide to What to Expect
Most content about peptide therapy focuses on the upside. This guide covers the full picture: the process, the timeline, the self-injection reality, and what questions to ask your provider.
TB-500: What It Is and What the Research Actually Shows
TB-500 is less talked about than BPC-157 but has a devoted following among athletes and patients with systemic injuries. Here is what the science says and who it tends to help.
Semax: What Patients Need to Know About This Cognitive Peptide
Semax has more human clinical evidence behind it than most peptides on this list. It is an approved drug in Russia, it targets BDNF, and it does not require injection. Here is the full picture.
Get the full series in your inbox
Before the Protocol is our free newsletter on peptide therapy, the FDA review, and what to know before you start.
Subscribe on Beehiiv